Here's Why You Should Hold DexCom Stock in Your Portfolio for Now [Yahoo! Finance]
DexCom, Inc. (DXCM)
Last dexcom, inc. earnings: 4/28 04:03 pm
Check Earnings Report
US:NASDAQ Investor Relations:
dexcom.com/investors
Company Research
Source: Yahoo! Finance
DexCom, Inc. DXCM is well positioned for growth in the coming quarters, supported by the significant potential of the continuous glucose monitoring (CGM) market. A strong fourth-quarter 2025 performance and a series of favorable coverage decisions are expected to contribute further. Risks related to stiff competition persist. This Zacks Rank #3 (Hold) company's shares have lost 16% in the past six months compared to the industry's 7.3% growth. The S&P 500 Index has gained 1.3% in the same time frame. DXCM, a renowned medical device company and provider of continuous glucose monitoring (CGM) systems, has a market capitalization of $24.72 billion. It projects a 20.6% growth rate over the next five years and anticipates maintaining a strong performance going forward. Zacks Investment Research Image Source: Zacks Investment Research DexCom's earnings surpassed the Zacks Consensus Estimate in three of the trailing four quarters and missed in one, the average surprise being 3.82%
Show less
Read more
Impact Snapshot
Event Time:
DXCM
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
DXCM alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
DXCM alerts
High impacting DexCom, Inc. news events
Weekly update
A roundup of the hottest topics
DXCM
News
- Is Dexcom (DXCM) Fairly Priced After Recent Share Price Pressure? [Yahoo! Finance]Yahoo! Finance
- Europe Blood Glucose Monitoring Market Report 2026-2031: Revenues to Exceed USD 9 Billion by 2031 [Yahoo! Finance]Yahoo! Finance
- We tried continuous glucose monitors from Lingo and Stelo for 2 weeks. Here's which one is better [CNN]CNN
- DexCom (DXCM) had its price target raised by Citigroup Inc. from $77.00 to $84.00. They now have a "buy" rating on the stock.MarketBeat
- Dexcom Showcases Breakthrough Outcomes for People With Type 2 Diabetes and Product Roadmap at ATTD 2026 [Yahoo! Finance]Yahoo! Finance
DXCM
Earnings
- 2/12/26 - Beat
DXCM
Sec Filings
- 3/16/26 - Form 144
- 3/10/26 - Form 4
- 3/10/26 - Form 4
- DXCM's page on the SEC website